Home » Topics » BioWorld Science

BioWorld Science
RSS

NIAID files IND application for phase IIa study of next-generation pertussis vaccine BPZE-1

May 17, 2018

Sumitomo Dainippon updates pipeline activities of fourth quarter of fiscal 2017

May 17, 2018

Cipher acquires Correvio's Canadian business portfolio

May 17, 2018

Rexahn advances phase IIa study of RX-3117 and Abraxane in metastatic pancreatic cancer

May 16, 2018

BioLamina and Novo Nordisk partner to develop novel stem cell-based therapies based on Biolaminins

May 16, 2018

Pivotal study of Dupixent in moderate to severe atopic dermatitis in adolescents meets key endpoints

May 16, 2018

V21-DOS47 immunoconjugate shows promising antitumoral activity in vivo

May 16, 2018

FDA approves Truvada to reduce risk of HIV-1 infection in adolescents

May 16, 2018

Otsuka highlights progress of first quarter 2018

May 16, 2018

Inovio reports new data from phase I study of HIV vaccine Pennvax-GP

May 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...